Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

od Magder, Laurence S., Petri, Michelle
Izdano 2012

Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort

od Petri, Michelle, Magder, Laurence S.
Izdano u Arthritis Rheumatol (2018)

Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss

od Mankee, Anil, Petri, Michelle, Magder, Laurence S
Izdano u Lupus Sci Med (2015)

Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE

od Domingues, Vinicius, Magder, Laurence S, Petri, Michelle
Izdano u Lupus Sci Med (2016)

Effect of mycophenolate mofetil on the white blood cell count and the frequency of infection in systemic lupus erythematosus

od Subedi, Ananta, Magder, Laurence S., Petri, Michelle
Izdano u Rheumatol Int (2015)

Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy

od Timlin, Homa, Magder, Laurence, Petri, Michelle
Izdano u Cureus (2017)

BLOOD PRESSURE VARIABILITY AND AGE-RELATED BLOOD PRESSURE PATTERNS IN SYSTEMIC LUPUS ERYTHEMATOSUS

od Stojan, George, Magder, Laurence S., Petri, Michelle
Izdano u J Rheumatol (2019)

Risk of Renal Failure within Ten or Twenty Years of SLE Diagnosis

od Petri, Michelle, Barr, Erik, Magder, Laurence S.
Izdano u J Rheumatol (2020)

Comparison of Seven Liver Allocation Models with Respect to Lives Saved Among Patients on the Liver Transplant Waiting List

od Magder, Laurence S., Regev, Arie, Mindikoglu, Ayse L.
Izdano 2012

Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years

od Kiani, Adnan N., Magder, Laurence S., Petri, Michelle
Izdano 2011

Development of a systemic lupus erythematosus cardiovascular risk equation

od Petri, Michelle A, Barr, Erik, Magder, Laurence S
Izdano u Lupus Sci Med (2019)

Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus

od Petri, Michelle A, Avci, Mertcan, Magder, Laurence S
Izdano u Lupus Sci Med (2020)

Survival associated pathway identification with group <it>L_p</it>penalized global AUC maximization

od Liu Zhenqiu, Magder Laurence S, Hyslop Terry, Mao Li
Izdano 2010-08-01

Survival associated pathway identification with group L(p )penalized global AUC maximization

od Liu, Zhenqiu, Magder, Laurence S, Hyslop, Terry, Mao, Li
Izdano 2010

Predictors of Organ Damage in Systemic Lupus Erythematosus: the Hopkins’ Lupus Cohort

od Petri, Michelle, Purvey, Sneha, Fang, Hong, Magder, Laurence S.
Izdano 2012

Impact of Estimated Liver Volume and Liver Weight on Gender Disparity in Liver Transplantation

od Mindikoglu, Ayse L., Emre, Sukru H., Magder, Laurence S.
Izdano 2012

Social capital and cost-related medication nonadherence (CRN): A retrospective longitudinal cohort study using the Health and Retirement Study data, 2006–2016

od Majercak, Kayleigh R., Magder, Laurence S., Villalonga-Olives, Ester
Izdano u SSM Popul Health (2020)

Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus

od Demir, Selcan, Li, Jessica, Magder, Laurence S, Petri, Michelle
Izdano u Rheumatology (Oxford) (2020)

Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus

od Kiani, Adnan N., Post, Wendy S., Magder, Laurence S., Petri, Michelle
Izdano 2011

Vitamin D in SLE: Modest Association with Disease Activity and Urine Protein/Creatinine Ratio

od Petri, Michelle, Bello, Kayode J., Fang, Hong, Magder, Laurence S.
Izdano 2013